NCT05231564

Hybrid Training and Middle Age

Completed NA Last updated 28 February 2022

What this trial tests

NA trial testing hybrid training in Women's Health in 15 participants. Completed in 1 February 2020.

Timeline

1 November 2019

Primary endpoint
2 December 2019

1 February 2020

Quick facts

Lead sponsor	University of Sistan and Baluchestan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	15
Start date	1 November 2019
Primary completion	2 December 2019
Estimated completion	1 February 2020
Sites	1 location across Iran

Drugs / interventions tested

• hybrid training

Conditions studied

• Women's Health — all drugs for Women's Health →
• Hybrid Training — all drugs for Hybrid Training →
• Middle Aged — all drugs for Middle Aged →
• Non-alcoholic Fatty Liver Disease — all drugs for Non-alcoholic Fatty Liver Disease →

Sponsor

University of Sistan and Baluchestan

Who can join

Adults 45 to 65, female only, with Women's Health or Hybrid Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Modern living and physical inactivity results in many ailments, including obesity, non-alcoholic fatty liver disease (NAFLD), and inflammatory issues.

Though there are a lot of studies on physical training, there is little detail on hybrid training or electrical and voluntary contractions of the musculature. This study investigated the efficiency of hybrid training in biochemistry, ultrasound, and proinflammatory outcomes in middle-aged sedentary and obese women with NAFLD.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. "Hybrid exercise training improves liver steatosis and inflammation in a randomized trial of sedentary, obese women with non-alcoholic fatty liver disease".
   Mohammadzadeh NZ, Rezaeipour M. · · 2025 · PMID 41137140 · DOI 10.1186/s13102-025-01349-2